HHS and the Drug Enforcement Administration have finalized a rule that expands telemedicine prescribing of buprenorphine for opioid use disorder, while also proposing a new special registration process for prescribing controlled substances remotely.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
